Inventor
Wang xi-tao
US22 patents
Patents
22 patentsUS10072082B2Sep 11, 2018
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
BRISTOL MYERS SQUIBB CO58 citations99
US10604575B2Mar 31, 2020
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
BRISTOL MYERS SQUIBB CO26 citations98
US10584170B2Mar 10, 2020
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
BRISTOL MYERS SQUIBB CO23 citations98
US10577423B2Mar 3, 2020
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
BRISTOL MYERS SQUIBB CO23 citations98
US10323093B2Jun 18, 2019
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
BRISTOL MYERS SQUIBB CO29 citations98
US10323092B2Jun 18, 2019
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
BRISTOL MYERS SQUIBB CO30 citations98
US10316091B2Jun 11, 2019
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
BRISTOL MYERS SQUIBB CO30 citations98
US10316090B2Jun 11, 2019
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
BRISTOL MYERS SQUIBB CO29 citations98
US10308714B2Jun 4, 2019
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
BRISTOL MYERS SQUIBB CO30 citations98
US10266594B1Apr 23, 2019
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
BRISTOL MYERS SQUIBB CO29 citations98
US10266595B2Apr 23, 2019
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
BRISTOL MYERS SQUIBB CO28 citations98
US10266596B1Apr 23, 2019
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
BRISTOL MYERS SQUIBB CO29 citations98
US10138299B2Nov 27, 2018
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
BRISTOL MYERS SQUIBB CO39 citations98
US9856320B2Jan 2, 2018
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
BRISTOL MYERS SQUIBB CO94 citations98
US9212224B2Dec 15, 2015
Antibodies that bind PD-L1 and uses thereof
BRISTOL MYERS SQUIBB CO135 citations97
US9644032B2May 9, 2017
Antibodies against OX40 and uses thereof
BRISTOL MYERS SQUIBB CO12 citations81
US12590154B2Mar 31, 2026
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
BRISTOL MYERS SQUIBB CO0 citations73
US10690674B2Jun 23, 2020
Anti-GITR antibodies for cancer diagnostics
BRISTOL MYERS SQUIBB CO5 citations71
US11466092B2Oct 11, 2022
Antibodies against OX-40 and uses thereof
BRISTOL MYERS SQUIBB CO1 citations70
US10683357B2Jun 16, 2020
Antibodies against OX40 and uses thereof
BRISTOL MYERS SQUIBB CO1 citations70
US11408889B2Aug 9, 2022
Anti-GITR antibodies for cancer diagnostics
BRISTOL MYERS SQUIBB CO1 citations61
US12139551B2Nov 12, 2024
Anti-IDO antibody and uses thereof
BRISTOL MYERS SQUIBB CO0 citations50